Compare Johnson & Johnson (JNJ) vs Direxion Daily 20 Year Treasury Bull 3X Shares (TMF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Direxion Daily 20 Year Treasury Bull 3X Shares — how do they compare? Johnson & Johnson trades at $261.44 (market cap $618.09B), while Direxion Daily 20 Year Treasury Bull 3X Shares trades at $25.99 (market cap $2.03B). The key difference: Johnson & Johnson is far larger — about 304.5× Direxion Daily 20 Year Treasury Bull 3X Shares's market cap, and Johnson & Johnson pays a 2.09% dividend while Direxion Daily 20 Year Treasury Bull 3X Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and Direxion Daily 20 Year Treasury Bull 3X Shares for 28 Days on average.
| JNJ | TMF | |
|---|---|---|
Market Cap | $618.09B | $2.03B |
Volume | 6,050,983 | 12,241,664 |
Sector | Health | Fixed Income |
52-Week High | $278.43 | $44.14 |
52-Week Low | $186.00 | $25.19 |
Typical Hold Time | 129 Days | 28 Days |
Enterprise Value | $646.37B | — |
Dividend Yield | 2.09% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $256.48, down 0.76% today, with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with 28.45% net profit margin and consistent revenue growth to $94.19B in 2025. Analyst consensus remains positive with a $286.53 price target, though technical indicators show resistance at $258 and support at $253. Recent news highlights pipeline strength including Icotyde's $4.5B peak sales potential (Bank of America, 2026-09-29).
JNJ presents a compelling long-term investment with diversified healthcare exposure and dividend stability, though near-term technical weakness and patent cliff concerns warrant caution. The 52.5% buy rating from analysts reflects confidence in innovation pipeline, while debt-to-asset ratio increase to 24.06% merits monitoring. Upside potential exists if Q3 earnings beat expectations on October 13.
TMF (Direxion Daily 20+ Year Treasury Bull 3X ETF) trades at $25.92, up 2.73% with increased volume of 5.2 million shares. Technical indicators show a bearish trend with strong selling pressure in moving averages, while oscillators remain neutral. The ETF saw heightened trading activity amid market focus on long-term Treasury movements.
As a leveraged Treasury ETF, TMF offers amplified exposure to long-term bond performance but carries significant volatility risks. Current market conditions suggest cautious positioning given the bearish technical signals and interest rate sensitivity. The absence of fundamental metrics typical of operating companies limits traditional valuation analysis.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Direxion Daily 20 Year Treasury Bull 3X Shares
TMF is a leveraged ETF that seeks to provide 300% (3x) of the daily performance of the ICE U.S. Treasury 20+ Year Bond Index. It is a tactical instrument used by sophisticated traders to capitalize on declining interest rates or to hedge against equity market volatility. Due to its daily reset mechanism and high expense ratio, TMF is structurally designed for short-term speculation rather than long-term buy-and-hold investing.
Read more on TMF →
